Skip to main content

Table 2 Patient demographics, outcomes and standard coagulation studies

From: Rotational thromboelastometry predicts thromboembolic complications after major non-cardiac surgery

  All (n =313) No thromboembolic complication (n =303) Thromboembolic complication (n =10) P-value
Age, years 58.7 (+/−15.2) 58.5 (+/-15.2) 63.6 (+/-16.1) 0.30
Body mass index, kg/m2 27.7 (+/-6.3) 27.8 (+/-6.3) 26.4 (+/-4.8) 0.49
Obesity 102 (32.6%) 99 (32.7%) 3 (30%) 0.57
Female 165 (53%) 161 (53%) 4 (40%) 0.88
Surgery class
Major abdominal 85 (27%) 81 (27%) 4 (40%) 0.47
Gynecological 4 (1%) 4 (1%) 0 (0%) 1.0
Central nervous system neurosurgery 48 (15%) 48 (16%) 0 (0% 0.37
Spine 62 (20%) 60 (20%) 2 (20%) 1.0
Vascular 11 (4%) 11 (4%) 0 (0%) 1.0
Urology 26 (8%) 23 (8%) 3 (30%) 0.04
Orthopedics 29 (9%) 29 (10%) 0 (0%) 0.60
Liver surgery 20 (6%) 19 (6%) 1 (10%) 0.49
Renal transplant 24 (8%) 24 (8%) 0 (0%) 1.0
Other 4 (1%) 4 (1%) 0 (0%) 1.0
Cancer 147 (47.0%) 141 (46.5%) 6 (60%) 0.62
End-stage renal disease 17 (5.4%) 17 (5.6%) 0 (0%) 1.0
Outcomes
ICU length of stay, days 1.1 (+/-3.8) 0.9 (+/-3.4) 5.7 (+/-9.7) 0.15
Hospital length of stay, days 6.8 (+/-10.1) 6.2 (+/-7.8) 25.5 (+/-32.4) 0.09
Myocardial infarction 3 (1%) 3 (1%) 0 (0%) 1.0
Acute kidney injury (RIFLE-risk) 12 (3.8%) 12 (3.9%) 0 (0%) 1.0
Standard postoperative coagulation studies
Prothrombin time, s 32.3 (+/-11.6) 32.3 (+/-11.8) 33.1 (+/-6.2) 0.89
International normalized ratio 1.20 (+/-0.24) 1.20 (+/-0.25) 1.28 (+/-0.11) 0.39
Platelet count 201 (+/-67) 201 (+/-68) 212 (+/-69) 0.63
  1. Data are reported as mean and standard deviation or number and percentage, as appropriate. Obesity = body mass index >30 m/kg2. RIFLE, risk, injury, failure, loss, end-stage renal failure; ns = not significant.